These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29045770)

  • 21. Efficacy of cognitive rehabilitation using computer software with individuals living with schizophrenia: A randomized controlled trial in Japan.
    Iwata K; Matsuda Y; Sato S; Furukawa S; Watanabe Y; Hatsuse N; Ikebuchi E
    Psychiatr Rehabil J; 2017 Mar; 40(1):4-11. PubMed ID: 28182471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial.
    Demant KM; Almer GM; Vinberg M; Kessing LV; Miskowiak KW
    Trials; 2013 Nov; 14():378. PubMed ID: 24206639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Vita A; Barlati S; Ceraso A; Nibbio G; Durante F; Facchi M; Deste G; Wykes T
    Am J Psychiatry; 2024 Jun; 181(6):520-531. PubMed ID: 38476043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief executive function training for individuals with severe mental illness: Effects on EEG synchronization and executive functioning.
    Best MW; Gale D; Tran T; Haque MK; Bowie CR
    Schizophr Res; 2019 Jan; 203():32-40. PubMed ID: 28931460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized controlled trial of exercise on augmenting the effects of cognitive remediation in persons with severe mental illness.
    McGurk SR; Otto MW; Fulford D; Cutler Z; Mulcahy LP; Talluri SS; Qiu WQ; Gan Q; Tran I; Turner L; DeTore NR; Zawacki SA; Khare C; Pillai A; Mueser KT
    J Psychiatr Res; 2021 Jul; 139():38-46. PubMed ID: 34022474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of cognitive remediation in patients with affective psychosis: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Biagianti B; Merchant J; Brambilla P; Lewandowski KE
    J Affect Disord; 2019 Aug; 255():. PubMed ID: 30878159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial.
    Twamley EW; Thomas KR; Burton CZ; Vella L; Jeste DV; Heaton RK; McGurk SR
    Schizophr Res; 2019 Jan; 203():41-48. PubMed ID: 28823720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial.
    Donohoe G; Dillon R; Hargreaves A; Mothersill O; Castorina M; Furey E; Fagan AJ; Meaney JF; Fitzmaurice B; Hallahan B; McDonald C; Wykes T; Corvin A; Robertson IH
    Psychol Med; 2018 Apr; 48(5):751-764. PubMed ID: 28933314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trial implementation of CIRCuiTS cognitive remediation therapy for people with schizophrenia in Orange, New South Wales.
    Thomas M; Rusten K
    Aust J Rural Health; 2019 Oct; 27(5):463-468. PubMed ID: 31663213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder.
    O'Reilly K; Donohoe G; O'Sullivan D; Coyle C; Corvin A; O'Flynn P; O'Donnell M; Galligan T; O'Connell P; Kennedy HG
    BMC Psychiatry; 2019 Jan; 19(1):27. PubMed ID: 30646884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder.
    Kantrowitz JT; Sharif Z; Medalia A; Keefe RS; Harvey P; Bruder G; Barch DM; Choo T; Lee S; Lieberman JA
    J Clin Psychiatry; 2016 Jun; 77(6):799-806. PubMed ID: 27035157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
    Burdick KE; Braga RJ; Nnadi CU; Shaya Y; Stearns WH; Malhotra AK
    J Clin Psychiatry; 2012 Jan; 73(1):103-12. PubMed ID: 22152405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Cognitive Remediation in Bipolar (CRiB) pilot study: study protocol for a randomised controlled trial.
    Strawbridge R; Fish J; Halari R; Hodsoll J; Reeder C; Macritchie K; McCrone P; Wykes T; Young AH
    Trials; 2016 Jul; 17():371. PubMed ID: 27472964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards personalizing cognitive remediation therapy: Examining moderators of response for euthymic people with bipolar disorder.
    Tsapekos D; Strawbridge R; Cella M; Wykes T; Young AH
    Behav Res Ther; 2022 Apr; 151():104054. PubMed ID: 35168010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of IPS plus cognitive remediation in early psychosis: 18-month functioning outcomes of a randomized controlled trial.
    van Duin D; de Winter L; Kroon H; Veling W; van Weeghel J
    Schizophr Res; 2021 Oct; 236():115-122. PubMed ID: 34482187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computerized cognitive remediation therapy, REHACOM, in first episode of schizophrenia: A randomized controlled trial.
    García-Fernández L; Cabot-Ivorra N; Rodríguez-García V; Pérez-Martín J; Dompablo M; Pérez-Gálvez B; Rodriguez-Jimenez R
    Psychiatry Res; 2019 Nov; 281():112563. PubMed ID: 31525673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
    Chengappa KN; Bowie CR; Schlicht PJ; Fleet D; Brar JS; Jindal R
    J Clin Psychiatry; 2013 Nov; 74(11):1076-83. PubMed ID: 24330893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia.
    Bryce SD; Lee SJ; Ponsford JL; Lawrence RJ; Tan EJ; Rossell SL
    Schizophr Res; 2018 Dec; 202():354-360. PubMed ID: 29935884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved functioning following computerized working memory training (COGMED®) in euthymic patients with bipolar disorder and cognitive complaints: An exploratory study.
    Lengvenyte A; Coppola F; Jaussent I; Courtet P; Olié E
    J Affect Disord; 2020 Feb; 262():414-421. PubMed ID: 31740107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.